精准医学在心脏病学中的研究格局
Shrinidhi Sivasubramaniam1, Keerthika Muniasamy2, Elakkiya L1
1Institute of Internal Medicine, Madras Medical College, Chennai, India.
Bioinformation
|October 31, 2025
概括
心脏病学中的精准医学使用患者数据来定制心脏护理. 基因组学和人工智能的进步改善了诊断,风险预测和治疗,尽管实施方面的挑战仍然存在.
科学领域:
- 心血管医学 心血管医学
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 精准医学整合了多组数据,以提供个性化的心血管护理.
- 越来越多地发现与心律不整,心肌病和冠状动脉疾病相关的遗传变异.
- 高通量技术和机器学习推进生物标志物发现和患者分层.
研究的目的:
- 审查目前的心脏病学准确医学的现状.
- 突出新兴技术及其应用.
- 讨论个性化心血管保健的未来方向.
主要方法:
- 关于精密心脏病学的最新进展的文献综述.
- 关于基因组,蛋白质组和表型数据整合的研究综合.
- 机器学习和药物遗传学应用的分析.
主要成果:
- 用于风险分层和向治疗的基因变异的识别.
- 发现了新的生物标志物和精细的表型子组.
- 证明了药物基因组学在优化药物治疗方面的潜力.
结论:
- 精准医学为改善心血管预防,诊断和治疗提供了显著的潜力.
- 数据整合,临床实施和伦理方面的挑战需要持续关注.
- 未来的研究和协作努力对于推进个性化心血管保健至关重要.
相关概念视频
Cardiomyopathy V: Interprofessional Care
326
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
326
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cardiomyopathy I: Introduction and Classification
490
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
490
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
777
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
777
Coronary Artery Disease I: Introduction
868
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
868


